The role of immunotherapy in early-stage and metastatic NSCLC
In the past decade we have seen new advances and thus remarkable progress in the therapeutic options for non-small cell lung cancer (NSCLC). Among cytostatic therapies with new approaches in molecularly targeted therapies, we see new developments in a wide range of applications for immunotherapies....
| Published in: | Pathology and Oncology Research |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-07-01
|
| Subjects: | |
| Online Access: | https://www.por-journal.com/articles/10.3389/pore.2024.1611713/full |